Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advancements in Life Sciences is Scopus-indexed (Q2, CiteScore 1.8), DOAJ. Published by The Running Line.
Checked against the index lists dated .
ISSN 2310-5380Verify ISSN ↗
Publisher: The Running Line
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 271 / 669 | 59th | Q2 |
| Veterinary (all) | 96 / 204 | 53rd | Q2 |
| Biochemistry, Genetics and Molecular Biology (all) | 147 / 223 | 34th | Q3 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q2, CiteScore 1.8.
Advancements in Life Sciences is Q2 in Medicine (all) (rank 271 of 669), Q2 in Veterinary (all) (rank 96 of 204) and Q3 in Biochemistry, Genetics and Molecular Biology (all) (rank 147 of 223), by CiteScore 2025.
Advancements in Life Sciences is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.8, quartile Q2, 59th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.201, quartile Q3, with an H-index of 14.
The publisher lists an article processing charge of about US$250 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Advancements in Life Sciences is published by The Running Line. Its ISSN is 2310-5380.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Advancements in Life Sciences has an h-index of 11 and a 2-year mean of 0.65 citations per paper (OpenAlex). Its Scopus CiteScore is 1.8, quartile Q2. On 2-year citations it ranks #334 of 646 Scopus journals in Medicine (all).
Advancements in Life Sciences published 113 papers in 2025; its busiest recent year was 2024 with 159. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 83 research articles (2025–2026), authors are most often from Iraq (39.2%), Saudi Arabia (26.1%) and Indonesia (5.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 33 retracted papers are recorded (50.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.